BONESUPPORT (Q3 Initial take): Slight miss, but accelerating long-term fundamentals - Redeye

Redeye gives its initial take on BONESUPPORT’s Q3 report. With a slight miss to our estimates on both sales and EBIT (and to consensus), we believe the market’s short-sightedness will not appreciate the reported figures. However, upon closer examination, we see a strong free cash flow and a rapidly accumulating cash position for a company with continued untapped potential, both in its extremities and its impending launch into spine. Still, we expect the share to trade in the negatives today, of about -3-5%

Länk till analysen i sin helhet: https://www.redeye.se/research/1132027/bonesupport-q3-initial-take-slight-miss-but-accelerating-long-term-fundamentals?utm_source=finwire&utm_medium=RSS